Dr. Johannes Schwenck, MD, PhD
Translat. and Preclin. Imaging in Inflamm. & Cancer
Email: johannes.schwenck( at )med.uni-tuebingen.de
Phone: +49 7071 29 86870
As a clinical scientist my interests lie in both advancing preclinical research as well as improving clinical health care. After conducting research on inflammatory processes during my MD thesis at the WSIC I am now focusing on inflammation driven cancer and immunotherapy. My current projects involving research on the carcinogenesis of hepatocellular carcinoma, the in vivo characterization of tumors like prostate cancer as well as secondary and tertiary lymphatic organs under immunotherapy. As a resident in Nuclear Medicine I am also heavily involved in the clinical translation of successful preclinical projects
Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT.
Schwenck J, Rempp H, Reischl G, Kruck S, Stenzl A, Nikolaou K, Pfannenberg C, la Fougère C
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):92-101